Literature DB >> 11806370

Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.

Maurizio Bonacini, Alan Kurz, Stephen Locarnini, Anna Ayres, Craig Gibbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11806370     DOI： 10.1053/gast.2002.30901

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.

Authors:  Steven-Huy B Han
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B.

Authors:  Satoshi Shakado; Hiroshi Watanabe; Takashi Tanaka; Daisuke Morihara; Shinya Nishizawa; Shinjiro Inomata; Syuichi Ueda; Teruo Matsumoto; Akira Anan; Yasuaki Takeyama; Makoto Irie; Kaoru Iwata; Tetsuro Sohda; Shotaro Sakisaka
Journal:  Hepatol Int       Date:  2008-05-30       Impact factor: 6.047

3.  Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant.

Authors:  Tatehiro Kagawa; Norihito Watanabe; Hisashi Kanouda; Ichiro Takayama; Tadahiko Shiba; Takashi Kanai; Kazuya Kawazoe; Shinji Takashimizu; Nobue Kumaki; Kazuo Shimamura; Shohei Matsuzaki; Tetsuya Mine
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

4.  Prevalence and Immunization Status of Hepatitis B Virus in the HIV Cohort in Fife, Scotland.

Authors:  Lukman Hakeem; Grace Thomson; Eleanor McCleary; Diptendu Bhattacharyya; Indranil Banerjee
Journal:  J Clin Med Res       Date:  2010-02-08

5.  Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.

Authors:  Eneida A Santos; Michel V F Sucupira; Juçara Arabe; Selma A Gomes
Journal:  BMC Infect Dis       Date:  2004-08-31       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.